ELV Q2 2022 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q2 2022 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$38.6B+14.1% YoY

Gross Profit

$9.8B25.5% margin

Operating Income

$2.3B6.0% margin

Net Income

$1.6B4.2% margin

EPS (Diluted)

$6.73

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

$2.5B

Free Cash Flow

$2.2B

Stock-Based Comp.

$72M

Balance Sheet

Total Assets

$100.9B

Total Liabilities

$65.0B

Stockholders' Equity

$35.8B

Cash & Equivalents

$6.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38.6B	$33.9B	+14.1%
Gross Profit	$9.8B	$9.1B	+8.2%
Operating Income	$2.3B	$2.6B	-9.1%
Net Income	$1.6B	$1.8B	-8.7%

Revenue Segments

Government Business Segment

$23.8B53%

Commercial Specialty Business Segment

$10.6B24%

IngenioRx Segment

$7.1B16%

Other Segment

$3.3B7%